ArticleClinical kidney journal2024

Reduction in kidney function decline and risk of severe clinical events in agalsidase beta-treated Fabry disease patients: a matched analysis from the Fabry Registry.

Julie L Batista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.